Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Principal Investigator
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.
The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy.
Bacterial lipoproteins can disseminate from the periphery to inflame the brain.
Mesolimbic Nociceptin Signaling and Cocaine Reward Suppression
See All 6 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mesolimbic Nociceptin Signaling and Cocaine Reward Suppression
Biography
contributor
Principal Investigator
Overview
sponsor award id
1R21DA058804-01A1
Time
start date
2024-07-01
end date
2026-06-30